Table 3. Number of positive episodes of each bacterium by type of sample.
| Microorganisms | Positive samples (%) | ||||
|---|---|---|---|---|---|
| Total | Rectal swabs | Pharyngeal swabs | Other | Isolate description | |
| A. baumanii | 55 | 45 (81.8) | 6 (10.9) | 4 (7.3) | 6 OXA-23 |
| VancoR enterococci | 20 | 20 (100.0) | 0 (0) | 0 (0) | 15 E. faecium; 4 E. faecalis; 1 E. casseliflavus |
| ESBL K. oxytoca | 5 | 5 (100.0) | 0 (0) | 0 (0) | – |
| ESBL K. pneumoniae | 68 | 63 (92.6) | 3 (4.4) | 2 (2.9) | – |
| P. aeruginosa | 23 | 21 (91.3) | 1 (4.3) | 1 (4.3) | 22 IMPase; 1 VIM |
| P. putida | 2 | 2 (100.0) | 0 (0) | 0 (0) | 2 VIM |
| MetiR S. aureus | 48 | 12 (25.0) | 36 (75.0) | 0 (0) | – |
| S. maltophilia | 23 | 12 (52.2) | 11 (47.8) | 0 (0) | – |
| A. xylosoxidans | 1 | 0 (0) | 1 (100.0) | 0 (0) | – |
| B. cenocepacia | 1 | 0 (0) | 1 (100.0) | 0 (0) | – |
OXA, oxacillinases; VancoR, vancomycin-resistant; ESBL, extended-spectrum β-lactamases; IMPase, carbapenemases type IMP; VIM, Verona integron-encoded metallo-beta-lactamase; MetiR, methicillin-resistant.